Global and China Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

Global and China Personalized Medicines In Oncology Market Size, Status and Forecast 2021-2027

  • QYResearch
  • January 2022
  • Healthcare
  • 107 pages

Report Description

Global Personalized Medicines In Oncology Scope and Market Size
Personalized Medicines In Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines In Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others

Segment by Application
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biotheranostics
Illumina
DNA Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
deCODE genetics
Exagen Inc

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Molecular Oncopathology
List of Tables
Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Molecular Oncopathology
Table 3. Key Players of Genome Diagnostics
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Oncology Testing

Success Stories

Our Clients